English
简体中文
Total: £ 56.28
2025-09-15 | Pages: 129 | Tables: 123
The global market for Emollient was estimated to be worth US$ 1380 million in 2024 and is forecast to a readjusted size of US$ 1636 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.Emollient is the medical word for a moisturiz...
2025-09-15 | Pages: 118 | Tables: 113
The global market for Aprotinin was estimated to be worth US$ 184120 million in 2024 and is forecast to a readjusted size of US$ 251140 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.Aprotinin, also known as bovine pancreati...
2025-09-15 | Pages: 104 | Tables: 93
The global market for Cytokines was estimated to be worth US$ 281530 million in 2024 and is forecast to a readjusted size of US$ 803580 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.Cytokines are a large group of small sig...
2025-09-15 | Pages: 104 | Tables: 102
The global market for Argatroban was estimated to be worth US$ 56.2 million in 2024 and is forecast to a readjusted size of US$ 37.8 million by 2031 with a CAGR of -5.6% during the forecast period 2025-2031.Argatroban is a synthetic direct thrombin i...
2025-09-15 | Pages: 93 | Tables: 109
The global market for Osteoporosis Drugs was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.Osteoporosis is a disease where decreased bone str...
2025-09-15 | Pages: 103 | Tables: 93
The global market for Contrast Agents was estimated to be worth US$ 6116 million in 2024 and is forecast to a readjusted size of US$ 9507 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.Contrast agents (or contrast media) is ...
2025-09-15 | Pages: 151 | Tables: 153
The global market for Avian Influenza Vaccines was estimated to be worth US$ 1100 million in 2024 and is forecast to a readjusted size of US$ 1592 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.Avian influenza refers to the ...
2025-09-15 | Pages: 104 | Tables: 93
The global market for Biosimilar Drug was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.Biosimilar drug is medicine made using a living syste...
2025-09-15 | Pages: 119 | Tables: 122
The global market for Chaga Mushroom Extract was estimated to be worth US$ 19.3 million in 2024 and is forecast to a readjusted size of US$ 24.4 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.Chaga mushroom extract is the bi...
2025-09-15 | Pages: 137 | Tables: 133
The global market for Contract Pharmaceutical Manufacturing was estimated to be worth US$ 97880 million in 2024 and is forecast to a readjusted size of US$ 145390 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.Contract Pharm...
2025-09-15 | Pages: 115 | Tables: 121
The global market for Natamycin was estimated to be worth US$ 210 million in 2024 and is forecast to a readjusted size of US$ 323 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.Natamycin, also sold as Natacyn, is a type of w...
2025-09-15 | Pages: 125 | Tables: 115
The global market for Meningococcal Vaccine was estimated to be worth US$ 285 million in 2024 and is forecast to a readjusted size of US$ 384 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.Meningococcal vaccine refers to any...
2025-09-15 | Pages: 100 | Tables: 101
The global market for Moxifloxacin HCl was estimated to be worth US$ 116 million in 2024 and is forecast to a readjusted size of US$ 110 million by 2031 with a CAGR of -0.8% during the forecast period 2025-2031.Moxifloxacin hydrochloride (moxifloxaci...
2025-09-15 | Pages: 100 | Tables: 110
The global market for Remifentanil Hydrochloride was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.Remifentanil Hydrochloride (also named Ult...
2025-09-15 | Pages: 95 | Tables: 109
The global market for Liraglutide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.Liraglutide (NN2211) is a long-acting glucagon-like pepti...
